GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) MULTIPLE MYELOMA DRUGS MARKET 2018, FORECAST TO 2023

Jan 2019 135

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Multiple myeloma is a cancer that forms in a type of white blood cell that is called a plasma cell. Plasma cells help to fight infections by making antibodies. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can cause complications. For people with multiple myeloma who require treatment, a number of treatments are available to help control the disease.

Scope of the Report:
This report focuses on the Multiple Myeloma Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Cancer cells have higher levels of proteasome activity are more sensitive to the proapoptotic effects of proteasome inhibition than normal cells, which makes the proteasome a therapeutic target in multiple myeloma. Proteasome inhibitor treatment is preferred after there is a treatment failure with the conventional approach.
The worldwide market for Multiple Myeloma Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
- Amgen
- Johnson & Johnson
- Celgene
- Takeda Pharmaceutical
- Novartis
- Daiichi Sankyo
- Merck
- AB Science
- Teva
- PharmaMar

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Immunomodulatory drugs (IMiDs)
- Proteasome inhibitors
- Chemotherapy
- Histone deacetylase inhibitor (HDAC inhibitor)
- Steroids (corticosteroids)

Market Segment by Applications, can be divided into
- Men
- Women

There are 15 Chapters to deeply display the global Multiple Myeloma Drugs market.
Chapter 1, to describe Multiple Myeloma Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Multiple Myeloma Drugs, with sales, revenue, and price of Multiple Myeloma Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Multiple Myeloma Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Multiple Myeloma Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Multiple Myeloma Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Jan 19)

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder S...

(Jan 19)

Veterinary Dermatology Drugs is the treatment for Atopic dermatitis of animals Scope of the Report: The worldwide mark...

(Jan 19)

Retinal Pharmaceuticals is primarily used to treat retinal-related diseases. Retina is a layer of nerve tissue lining the back of the...

(Jan 19)

Sports Nutrition Powders is mainly used as a nutritional supplement for occupational, semi-professional and leisure athletes. ...

(Jan 19)

Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B a...

(Jan 19)

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases....

GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) MULTIPLE MYELOMA DRUGS MARKET 2018, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy